- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01388023
Day Long Prevention of Oral Malodor With a Palatal Patch (SmellX) Containing A Herbal Formula (SmellX)
Phase 2 Clinical Study of a Day Long Effect of SmellX Palatal Patch Containing A Herbal Formula on Malodor
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Oral malodor is a common complaint among dental patients. This condition derives in most cases form the putrefactive activities of oral microorganisms, primarily anaerobic Gram negative bacteria. These bacteria reside on various locations within the oral cavity (e.g. tongue dorsum, interdental space, periodontal pockets, faulty and leaky restorations and tonsils) and breakdown salivary and oral proteins into their amino acid building blocks. Some of these amino acids (e.g. methionine and cysteine) are further metabolized yielding malodorous volatile sulfide compounds (VSC) such as methylmercaptan and hydrogen sulfide.The tongue dorsum and especially its posterior portion are considered the key location for this process. Therefore, the treatment regiment includes in most cases a daily use of tongue scrapers and mouthwashes. Indeed, a recent Cochrane systematic review found tongue scrapers to have short-term efficacy in controlling halitosis.
However, the use of tongue scrapers is unpleasant and induces in many cases a strong gag reflex, and apparently has very little effect on bacterial load of the tongue.
Furthermore, some mouthwashes have been shown to cause adverse side effects such as tooth staining. In a previous study we performed a set of related experiments on a new sustained release delivery system in the form of an adhesive tablet containing an herbal formulation. The adhesive tablet is applied to the palate. This places it right above, and in direct contact with the tongue dorsum, thus allowing a sustained release of the active ingredients directly to the target site. The ingredients of the herbal formulation have been previously shown to reduce malodor production in a salivary incubation assay. We tested the effect of this system on oral malodor production and VSC levels in a young healthy population, and the antimicrobial effect of its active ingredients on three known oral pathogens (Streptoccocus mutans, Porphyromonas gingivalis and Candida albicans. In this study we intend to examine a day long protocol to achieve a relief from oral halitosis for 24 houres.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
-
Jerusalem, Israel, 49453
- Hadassah Medical Organization,
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- random gender
- age
- healthy people
Exclusion Criteria:
- used antibiotics in the last three months
- suffer from systemic disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: smellx
test group- SmellX palatal patch with the herbal formula
|
composition of herbal ingridients in a palatal mucoadhesive patch to remove volatile solfur compounds and reducequantity of vsc creating bacteria
Other Names:
|
PLACEBO_COMPARATOR: smellx palatal patch
negative control group- SmellX palatal patch with out the herbal formula
|
composition of herbal ingridients in a palatal mucoadhesive patch to remove volatile solfur compounds and reducequantity of vsc creating bacteria
Other Names:
|
ACTIVE_COMPARATOR: chlorhexidine
poositive control group-mouth wash with chlorhexidine 0.125%
|
composition of herbal ingridients in a palatal mucoadhesive patch to remove volatile solfur compounds and reducequantity of vsc creating bacteria
Other Names:
|
ACTIVE_COMPARATOR: listerine
listerine mouth wash
|
composition of herbal ingridients in a palatal mucoadhesive patch to remove volatile solfur compounds and reducequantity of vsc creating bacteria
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
reduction of VSC measurements with halimeter
Time Frame: 24 hr
|
volatile solfur compounds can be measured with a halimeter as an indication of halitosis.
decrease of vsc value from base line indicates success in reducing halitosis
|
24 hr
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
reduction of halitosis as measured by judge score
Time Frame: 24 hr
|
judge score of halitosis on a scale of 1-5 is the gold standart for halitosis measurments.
levels lower than base line indicate success in the treatment of halitosis
|
24 hr
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Michael M Perez Davidi, DMD, Hadassah Medical Centers The hebrew university Jerusalem
Publications and helpful links
General Publications
- Perez Davidi M, Beyth N, Sterer N, Feuerstein O, Weiss EI. Effect of liquid-polish coating on in vivo biofilm accumulation on provisional restorations: part 1. Quintessence Int. 2007 Jul-Aug;38(7):591-6.
- Mizrahi B, Golenser J, Wolnerman JS, Domb AJ. Adhesive tablet effective for treating canker sores in humans. J Pharm Sci. 2004 Dec;93(12):2927-35. doi: 10.1002/jps.20193.
- Sterer N, Rubinstein Y. Effect of various natural medicinals on salivary protein putrefaction and malodor production. Quintessence Int. 2006 Sep;37(8):653-8.
- Sterer N. Antimicrobial effect of mastic gum methanolic extract against Porphyromonas gingivalis. J Med Food. 2006 Summer;9(2):290-2. doi: 10.1089/jmf.2006.9.290.
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1910552HMO-CTIL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gingivitis
-
Zainab J AbbasCompleted
-
University of SaskatchewanCompletedChronic Gingivitis | Chronic Gingivitis, Plaque InducedCanada
-
Tufts UniversityGuangdong Bixdo Health Technology Co., Ltd.Not yet recruitingPlaque Induced GingivitisUnited States
-
Cairo UniversityNot yet recruiting
-
Hospital Universiti Sains MalaysiaRecruitingGingivitis | Plaque Induced GingivitisMalaysia
-
Lander Enterprises, LLCCompletedPlaque Induced GingivitisUnited States
-
University of WashingtonColgate PalmoliveCompleted
-
Tokat Gaziosmanpasa UniversityAbant Izzet Baysal UniversityCompletedPregnancy Gingivitis
-
Maharishi Markendeswar University (Deemed to be...CompletedChronic GingivitisIndia
-
Kırıkkale UniversityCompletedSmoking | Gingivitis; Chronic
Clinical Trials on herbal formula for fresh breath
-
University of Alabama at BirminghamCompleted
-
University Hospital, ToulouseRecruiting
-
Carmel Medical CenterUnknownAsthma | Chronic Obstructive Lung DiseaseIsrael
-
Carmel Medical CenterUnknown
-
Menssana Research, Inc.University of Erlangen-Nürnberg; Zuyderland Medical Centre; Mount Vernon Cancer...Not yet recruitingBreast Cancer | Abnormal Mammogram, UnspecifiedNetherlands, Germany, United Kingdom
-
Abbott NutritionTerminatedRespiratory Infections in ChildrenUnited States
-
Keimyung University Dongsan Medical CenterUnknownInflammatory Bowel Disease | Volatile Organic CompoundsKorea, Republic of
-
NestléCompletedInfant, Premature, NutritionVietnam
-
Chang Gung Memorial HospitalTaipei Veterans General Hospital, Taiwan; Taipei Medical University; National...Not yet recruitingAtopic Dermatitis
-
Johns Hopkins UniversityUnited States Department of Defense; MU-JHU CARE; Terumo BCTRecruitingTransfusion-Transmitted Infectious DiseaseUganda